NEXTBIOMEDICAL Co., Ltd. Logo

NEXTBIOMEDICAL Co., Ltd.

Develops polymer-based drug-device solutions for hemostasis and drug delivery worldwide.

389650 | KO

Overview

Corporate Details

ISIN(s):
KR7389650003
LEI:
Country:
South Korea
Address:
인천광역시 연수구 벤처로100번길 6, 인천광역시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

NEXTBIOMEDICAL Co., Ltd. is a global company specializing in innovative therapeutic solutions designed to address unmet clinical needs. The company develops and commercializes first-in-class products based on its proprietary polymer core technology, which enables advanced drug-device combination platforms. Key technologies include biodegradable adhesive polymers and resorbable microspheres for applications like sustained drug delivery. A flagship product is Nexpowder, an endoscopic hemostatic agent for gastrointestinal bleeding. Through strategic global partnerships, including a collaboration with Medtronic, NEXTBIOMEDICAL aims to establish its innovations as new standards of care worldwide.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-11 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.1 KB
2025-09-05 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.0 KB
2025-08-14 00:00
Interim / Quarterly Report
반기보고서 (2025.06)
Korean 947.3 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 792.4 KB
2025-03-31 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 98.2 KB
2025-03-24 00:00
AGM Information
정기주주총회결과
Korean 20.3 KB
2025-03-13 00:00
Audit Report / Information
감사보고서제출
Korean 22.7 KB
2025-03-13 00:00
Annual Report
사업보고서 (2024.12)
Korean 1.1 MB
2025-03-11 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집공고
Korean 88.0 KB
2025-03-06 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 84.7 KB
2025-02-20 00:00
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
Korean 23.4 KB
2025-02-12 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 10.2 KB
2025-02-12 00:00
Share Issue/Capital Change
주식매수선택권부여에관한신고
Korean 14.9 KB
2025-02-04 00:00
Earnings Release
매출액또는손익구조30%(대규모법인은15%)이상변동
Korean 11.0 KB
2024-12-24 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.8 KB

Automate Your Workflow. Get a real-time feed of all NEXTBIOMEDICAL Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for NEXTBIOMEDICAL Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for NEXTBIOMEDICAL Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

KWANGDONG PHARMACEUTICAL CO.,LTD Logo
Developing drugs & health goods by integrating oriental and Western medicine.
South Korea
009290
Kyivmedpreparat Logo
A leading pharmaceutical producer of antibacterial, generic, and original medicines in various forms.
Ukraine
KMED
KYONGBO PHARMACEUTICAL CO., LTD. Logo
Manufactures APIs and finished drugs, offering global CDMO services from development to production.
South Korea
214390
KYORIN Pharmaceutical Co., Ltd. Logo
Researches, develops, and sells a portfolio of ethical, generic, and OTC medicines.
Japan
4569
Kyowa Kirin Co.,Ltd. Logo
Develops antibody medicines for oncology, nephrology, immunology, and allergy.
Japan
4151
KyungdongPharm Logo
Develops and manufactures Rx/OTC drugs & APIs for cardiology and other chronic conditions.
South Korea
011040
KYUNG NAM PHARM.CO.,LTD. Logo
South Korean maker of OTC medicines, health foods, and cosmetics, known for its Lemona Vitamin C.
South Korea
053950
Kyverna Therapeutics, Inc. Logo
Developing CAR T-cell therapies for durable remission in autoimmune diseases.
United States of America
KYTX
Labiana S.A. Logo
Pharmaceutical CDMO for animal & human health with its own line of vaccines and generics.
Spain
LAB

Talk to a Data Expert

Have a question? We'll get back to you promptly.